These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20202650)

  • 21. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
    Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G;
    J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are initial demyelinating event recovery and time to second event under differential control?
    West T; Wyatt M; High A; Bostrom A; Waubant E
    Neurology; 2006 Sep; 67(5):809-13. PubMed ID: 16966542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of acute pancreatitis: a long-term population-based study.
    Lankisch PG; Breuer N; Bruns A; Weber-Dany B; Lowenfels AB; Maisonneuve P
    Am J Gastroenterol; 2009 Nov; 104(11):2797-805; quiz 2806. PubMed ID: 19603011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical longitudinal study of multiple sclerosis in Cantabria, Spain.
    Morís G; Berciano J; Miró J
    Neurologia; 2003 Dec; 18(10):723-30. PubMed ID: 14648348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sibling disability risk at onset and during disease progression in familial multiple sclerosis.
    Wellek A; Korsukewitz C; Bach JP; Schock S; Eienbröker C; Seitz F; Spengler A; Hemmer B; Schlegel K; Oertel WH; Sommer N; Tackenberg B
    Mult Scler; 2011 Sep; 17(9):1060-6. PubMed ID: 21561958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoking and progression in multiple sclerosis.
    Koch M; van Harten A; Uyttenboogaart M; De Keyser J
    Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
    Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
    Kingwell E; Leung AL; Roger E; Duquette P; Rieckmann P; Tremlett H;
    J Neurol Sci; 2010 May; 292(1-2):57-62. PubMed ID: 20202651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis and epileptic seizures.
    Catenoix H; Marignier R; Ritleng C; Dufour M; Mauguière F; Confavreux C; Vukusic S
    Mult Scler; 2011 Jan; 17(1):96-102. PubMed ID: 20861180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
    Novotna M; Paz Soldán MM; Abou Zeid N; Kale N; Tutuncu M; Crusan DJ; Atkinson EJ; Siva A; Keegan BM; Pirko I; Pittock SJ; Lucchinetti CF; Noseworthy JH; Weinshenker BG; Rodriguez M; Kantarci OH
    Neurology; 2015 Aug; 85(8):722-9. PubMed ID: 26208962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
    Shirani A; Zhao Y; Kingwell E; Rieckmann P; Tremlett H
    Mult Scler; 2012 Apr; 18(4):442-50. PubMed ID: 21952097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis.
    Cossburn M; Ingram G; Hirst C; Ben-Shlomo Y; Pickersgill TP; Robertson NP
    Mult Scler; 2012 Jan; 18(1):45-54. PubMed ID: 21865412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognosis and factors that predict outcome in multiple sclerosis].
    Matsui M
    Nihon Rinsho; 2003 Aug; 61(8):1396-401. PubMed ID: 12962029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for survival in multiple sclerosis.
    Lević ZM; Dujmović I; Pekmezović T; Jarebinski M; Marinković J; Stojsavljević N; Drulović J
    Mult Scler; 1999 Jun; 5(3):171-8. PubMed ID: 10408717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.